Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Yiangou

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Digestive Diseases and Sciences|October 1, 1983
Peptide histidine isoleucine (PHI). A secretagogue in porcine intestineA A Anagnostides, K Manolas, N D Christofides, et al.
Experientia|May 15, 1984
Comparative distribution of vasoactive intestinal polypeptide (VIP), substance P and PHI in the enteric sphincters of the catG P McGregor, A E Bishop, M A Blank, et al.
The American Journal of Pathology|June 1, 1990
Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expressionG Rindi, S G Grant, Y Yiangou, et al.
Gastroenterology|September 1, 1985
Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like moleculeY Yiangou, N D Christofides, M A Blank, et al.
Neurogastroenterology and Motility|September 29, 2001
ATP-gated ion channel P2X(3) is increased in human inflammatory bowel diseaseY Yiangou, P Facer, P A Baecker, et al.
Endocrinology|November 1, 1984
Distribution of peptide histidine isoleucine in the mammalian respiratory tract and some aspects of its pharmacologyN D Christofides, Y Yiangou, P J Piper, et al.
BJU International|March 31, 2004
Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatmentC M Brady, A N Apostolidis, M Harper, et al.
The Journal of Urology|August 12, 2005
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivityA Apostolidis, R Popat, Y Yiangou, et al.
BJU International|February 7, 2004
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxinA N Apostolidis, Y Yiangou, C M Brady, et al.
Peptides|January 1, 1986
A VIP/PHI-containing pathway links urinary bladder and sacral spinal cordS J Gibson, J M Polak, P Anand, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Digestive Diseases and Sciences|October 1, 1983
Peptide histidine isoleucine (PHI). A secretagogue in porcine intestineA A Anagnostides, K Manolas, N D Christofides, et al.
Experientia|May 15, 1984
Comparative distribution of vasoactive intestinal polypeptide (VIP), substance P and PHI in the enteric sphincters of the catG P McGregor, A E Bishop, M A Blank, et al.
The American Journal of Pathology|June 1, 1990
Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expressionG Rindi, S G Grant, Y Yiangou, et al.
Gastroenterology|September 1, 1985
Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like moleculeY Yiangou, N D Christofides, M A Blank, et al.
Neurogastroenterology and Motility|September 29, 2001
ATP-gated ion channel P2X(3) is increased in human inflammatory bowel diseaseY Yiangou, P Facer, P A Baecker, et al.
Endocrinology|November 1, 1984
Distribution of peptide histidine isoleucine in the mammalian respiratory tract and some aspects of its pharmacologyN D Christofides, Y Yiangou, P J Piper, et al.
BJU International|March 31, 2004
Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatmentC M Brady, A N Apostolidis, M Harper, et al.
The Journal of Urology|August 12, 2005
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivityA Apostolidis, R Popat, Y Yiangou, et al.
BJU International|February 7, 2004
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxinA N Apostolidis, Y Yiangou, C M Brady, et al.
Peptides|January 1, 1986
A VIP/PHI-containing pathway links urinary bladder and sacral spinal cordS J Gibson, J M Polak, P Anand, et al.
Pageof 6